Skip to main content
SpringerLink
Log in
Book cover

Combined Modality Therapy of Central Nervous System Tumors pp 145–165Cite as

Surgical Management of Pituitary Adenoma

  • Chapter

  • 178 Accesses

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

Abstract

Pituitary adenomas are benign tumors which originate from any of the multiple cell types of the anterior pituitary gland. These tumors come to clinical attention when they result in signs and symptoms of an endocrinopathy, or when they achieve sufficient size to produce mass effect. Surgical resection is usually curative for these benign lesions. However, therapeuticther conundrums arise when total surgical resection is not feasible.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adams CBT: (1988) The management of pituitary tumours and post-operative visual deterioration. Acta Neurochir (Wien) 94:103–116

    Article  CAS  Google Scholar 

  • Albuquerque FC, Hinton DR, Weiss MH: Elevation of serum prolactin due to stalk section effect. J Neurosurg. In press Alford FP, Arnott R: (1992) Medical management of pituitary tumors. Med J Austr 157:57–60

    Google Scholar 

  • Amar AP, Chen JCT, Couldwell WT, Weiss MH: (1998) Predictive value of immediate serum prolactin levels following transsphenoidal surgery. J Neurosurg 88:392A-393 A (abstract)

    Google Scholar 

  • Arafah B: (1986) Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 62:1173

    Article  PubMed  CAS  Google Scholar 

  • Arafah BH, Brodkey JS, Kaufman B, Velasco M, Manni A, Pearson OH. (1980) Transsphenoidal Microsurgery in the Treatment of Acromegaly and Gigantism. J Clin Endocrinol Metab 50:578

    Article  PubMed  CAS  Google Scholar 

  • Arafah BM, Rosenzweig JL, Fenstermaker R, Salazar R, McBride CE, Selman W. (1987) Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly. J Lab Clin Med 109: 346–354

    PubMed  CAS  Google Scholar 

  • Aristzabal S, Caldwell WL, Avila J: (1977) The relationship of time-dose fractionation factors to complications in the treatment of pituitary tumors by irradiation. Int J Radiat Oncol Biol Phys 2:667–673

    Article  Google Scholar 

  • Aron DC, Tyrrell JB, Wilson CB. (1995) Pituitary Tumors. Current Concepts in Diagnosis and Management. West J Med 162: 340–352

    PubMed  CAS  Google Scholar 

  • Baglan R, Marks J: (1981) Soft-tissue reactions following irradiation of primary brain and pituitary tumors. Int J Radiat Oncol Biol Phys 7:455–459

    Article  PubMed  CAS  Google Scholar 

  • Barkan A, Lloyd RV, Chandler WF, et al: (1988) Treatment of acromegaly with SMS 201–995 (sandostatin): Clinical, biochemical and morphologic study, in Lamberts SWJ (ed): Sandostatin in the treatment of acromegaly. New York, Springer,pp 201–995

    Google Scholar 

  • Barkan AL, Kelch RP, Hopwood NJ, Beitins IZ: (1988) Treatment of acromegaly with the long-acting somatostatin analog SMS 201–995, J Clin Endocrinol Metab 66:201–995

    Article  PubMed  CAS  Google Scholar 

  • Barkan AL: (1992) Acromegaly. Trends Endocrinol Metab 3: 205–210

    Google Scholar 

  • Barnard LB, Grantham WG, Lamberton P, et al: (1986) Treatment of resistant acromegaly with a long-acting somatostatin analogue (SMS 201–995). Ann Intern Med 105:201–995

    PubMed  CAS  Google Scholar 

  • Baskin DS, Boggan JE, Wilson CB: (1982) Transsphenoidal microsurgical removal of growth hormone-secreting pituitary adenomas. A review of 137 cases. J Neurosurg 56:634–641

    Article  PubMed  CAS  Google Scholar 

  • Bauer W, Briner U, Doepfner W, et al: (1982) SMS 201–995: A very potent selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31:201–995

    Article  PubMed  CAS  Google Scholar 

  • Baumann G: (1987) Acromegaly. Endocrinol Metab Clin North Am 16:685–702

    Google Scholar 

  • Bengtsson, BA, Eden S, Ernest I, Oden A, Sjogren B: (1988) Epidemiology and long term survival in acromegaly. Acta Med Scandinav 223: 327–335

    Article  CAS  Google Scholar 

  • Bevin JS, Adams CBT, Burke CW et al: (1987) Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumor, including pre-operative bromocriptine therapy. Clin Endocrinol 26:541

    Article  Google Scholar 

  • Bloom HTG: (1973) Radiotherapy of pituitary tumors, in Jenkins JS (ed): Pituitary Tumors. Butterworth, London, pp 165–197

    Google Scholar 

  • Breidahl HD, Topliss DJ, Pike JW: (1983) Failure of bromocriptine to maintain reduction in size of a macroprolactinoma. Br Med J 287:451–452

    Article  CAS  Google Scholar 

  • Buchfelder M, Brockmeier S, Fahlbusch R, Honegger J, Pichl J, Manzl M. (1991) Recurrence following Transsphenoidal Surgery for Acromegaly. Horm Res 35: 113–118

    Article  PubMed  CAS  Google Scholar 

  • Buchfelder M, Fahlbusch R, Schott W, Honegger J: (1991) Long-term follow-up results in hormonally active pituitary adenomas after primary successful transsphenoidal surgery. Acta Neurochir Suppl 53:72–76

    Article  PubMed  CAS  Google Scholar 

  • Canales ES, Garcia IC, Ruiz JE, et al: (1981) Bromocriptine as prophylactic therapy in prolactinoma during pregnancy. Fertil Steril 36:524–526

    PubMed  CAS  Google Scholar 

  • Charest L, Comtois R, Beaureguard H, Serri O: (1989) Growth hormone rebound after cessation of SMS 201–995 treatment in acromegaly. Can J Neurol Sci 16:201–995

    PubMed  CAS  Google Scholar 

  • Christensen SE, Weeke J, Orskov H, et al: (1987) Continuous subcutaneous pump infusion of somatostatin analogue SMS 201–995 versus subcutaneous injection schedule in acromegalic patients. Clin Endocrinol 27:201–995

    Article  CAS  Google Scholar 

  • Chun M, Masko GB, Hetelekidis S: (1988) Radiotherapy in thetreatment of pituitary adenomas. Int J Radiat Oncol Biol Phys 15:305–309

    Article  PubMed  CAS  Google Scholar 

  • Ciric I, Mikhael M, Stafford T, et al: (1984) Transsphenoidal microsurgery of pituitary macroadenomas with longterm follow-up results. J Neurosurg 59:395–401

    Google Scholar 

  • Ciric IS, Tarkington J: (1974) Transsphenoidal microsurgery. Surg Neurol; 2:207

    PubMed  CAS  Google Scholar 

  • Cohen AR, Cooper PR, Kupersmith MJ et al: (1985) Visual recovery after transsphenoidal removal of pituitary adenomas. Neurosurg 17:446

    Article  CAS  Google Scholar 

  • Collins WF: (1979) Pituitary tumor management: an overview. P. 179. In Tindall GT, Collins WF (eds): Clinical Management of Pituitary Disorders. Raven Press, New York Corrodi H, Fuxe K, Hokfelt T, et al: (1973) Effect of ergot drugs on central cathecolamine neurons: Evidence for stimulation of central dopamine neurons. PharmPharmacol 25:409

    Google Scholar 

  • Crosignani PG, Mattei A, Ferrari C, et al: (1982) Enlargement of a prolactin-secreting pituitary macroadenoma during bromocriptine. Br J Obstet Gynecol 89:169–170

    Article  CAS  Google Scholar 

  • Cunnah D, Besser M: (1991) Management of prolactinomas. Clin Endocrinol 34:231–235

    Article  CAS  Google Scholar 

  • Davis DH, Laws ER, Ilstrup DM, Speed JK, Caruso M, Shaw EG, Abboud CF, Scheithauer BW, Rood LM, Schleck C. (1993) Results of surgical treatment for growth hormonesecreting pituitary adenomas. J Neurosurg 79: 70–75

    Article  PubMed  CAS  Google Scholar 

  • Evans WS, Thorner MO: (1984) Mechanisms for hypogonadism in hyperprolactinemia. Semin Reprod Endocrinol 2:9–22

    Article  Google Scholar 

  • Ezzat S, Snyder PJ, Young WF, et al: (1992) Octreotide treatment of acromegaly. A randomized, multicenter study.

    Google Scholar 

  • Ann Intern Med 117:711–718

    Google Scholar 

  • Fahlbusch R, Buchfelder M, Schrell U: (1987) Short-term preoperative treatment of macroprolactinomas by dopamine agonists. J Neurosurg 67:807–815

    Article  PubMed  CAS  Google Scholar 

  • Fahlbusch R, Honegger J, Buchfelder M. (1992) Surgical Management of Acromegaly. Endocrin and Met Clinics North America 21: 669–692.

    CAS  Google Scholar 

  • Frohman LA: (1991) Therapeutic options in acromegaly. J Clin Endocrinol Metab 72:1175–1181

    Article  PubMed  CAS  Google Scholar 

  • Gemzell C, Wang CF: (1979) Outcome of pregnancy in women with pituitary adenoma. Fertil Steril 31:363–372

    PubMed  CAS  Google Scholar 

  • George SR, Kovacs K, Asa SL, et al: (1987) Effect of SMS 201–995, a long-acting somatostatin analogue, on the secretion and morphology of a pituitary growth hormone cell adenoma.Clin Endocrinol (Oxf) 26:201–995

    Google Scholar 

  • Giannella-Neto D, Wajchenberg BL, Mendonca BB, Almeida SF, Macchione M, Spencer EM. (1988) Criteria for the cure of acromegaly: comparison between basal growth hormoneand somatomedin C plasma concentrations in active and non-active acromegalic patients. J Endocrinol Invest 11:57

    PubMed  CAS  Google Scholar 

  • Giovanelli M, Losa M, Mortini P, Acerno S, Giugni: (1996) Surgical results in microadenomas. Acta Neurochir Suppl 65:11–12

    PubMed  CAS  Google Scholar 

  • Gramegna A: (1909) Un cas d¡¯acromegalie traitJ par la radiotherapie. Rev Neurol 17:15

    Google Scholar 

  • Greenspan SL, Oppenheim DO, Klibaski A: (1989) Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med110:526–531

    Google Scholar 

  • Grisoli F, Brue T, Graziani N, et al: (1990) Enlarged adenomectomy for enclosed prolactinomas: A preliminarystudy of 26 cases. Acta Neurochir (Wien) 103:92–98

    Article  CAS  Google Scholar 

  • Hardy J, Somma M: (1979) Acromegaly: surgical treatment by transsphenoidal microsurgical removal of the pituitary adenoma, in Tindall GT, Collins WF (eds): Clinical Management of Pituitary Disorders. New York: Raven Press, pp209–217

    Google Scholar 

  • Hardy J: (1971) Transsphenoidal hypophysectomy. J Neurosurg 34:582

    Article  PubMed  CAS  Google Scholar 

  • Hardy J: (1969) Transsphenoidal microsurgery of the normal and pathological pituitary. Clin Neurosurg 16: 185.

    PubMed  CAS  Google Scholar 

  • Harris AG, Prestele H, Herold K, et al: (1988) Long-term efficacy of sandostatin (SMS 201–995, octreotide) in 178 acromegalic patients: Results from the International Multicenter Acromegaly Study Group, in Lamberts SWJ (ed): Sandostatin in the Treatment of Acromegaly. New York, Springer, pp 201–995

    Google Scholar 

  • Ho KY, Weissberger AJ, Marbach P, Lazarus L. (1990) Therapeutic efficacy of the somatostatin analog SMS 201–995 (octreotide) in acromegaly. Ann Intern Med 112:201–995

    PubMed  CAS  Google Scholar 

  • Ho PJ, Barkan AL: Acromegaly, in Bardin CW (ed): (1991) Current Therapy in Endocrinology and Metabolism, 4th ed. Philadelphia, B.C. Decker Inc, pp 38–43

    Google Scholar 

  • Hubbard JL, Scheithauer BW, Abboud CF, Laws ER Jr: (1987) Prolactin-secreting adenomas: The preoperative response to bromocriptine treatment and surgical outcome. JNeurosurg 67:816–821

    Article  CAS  Google Scholar 

  • Hulting AL, Muhr C, Lundberg PO, Werner S: (1985) Prolactinoma in men: Clinical characteristics and the effect of bromocriptine treatment. Acta Med Scand 217:101–109

    Article  PubMed  CAS  Google Scholar 

  • Jackson I, Barnard LB, Lamberton P: (1986) Role of longacting somatostatin analogue (SMS 201–995) in the treatment of acromegaly. Am J Med 81(Suppl 6-):201–995

    Article  PubMed  CAS  Google Scholar 

  • Jacobs HS, Franks S, Murray MAF, et al: (1976) Clinical and endocrine features of hyperprolactinemic amenorrhea. Clin Endocrinol (Oxf) 5:439–454

    Article  CAS  Google Scholar 

  • Kjellberg RN, Kliman B, Swisher BJ. (1980) Radiosurgery for pituitary adenoma with Bragg peak proton beam. In Derome PJ, Jedynak CP, Peillon F, eds. Pituitary adenomas,biology, physiopathology and treatment: Second European Workshop La Pitie-Salpetriere, Paris. Paris: Asclepios Publishing 209–217

    Google Scholar 

  • Klibanski A, Greenspan SL: (1986) Increase in bone mass after treatment of hyperprolactinemic amenorrhea. N Engl J Med 315:542–546

    Article  PubMed  CAS  Google Scholar 

  • Klibanski A, Zervas NT: (1991) Diagnosis and management of hormone-secreting pituitary adenomas. N Engl J Med 324:822–831

    Article  PubMed  CAS  Google Scholar 

  • Konopka P, Raymond JP, Merceron RE, et al: (1983) Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women withprolactinomas. Am J Obstet Gynecol 146:935–938

    PubMed  CAS  Google Scholar 

  • Kramer S: (1968) The value of radiation therapy for pituitary and parapituitary tumors. Can Med Assoc J 99:1120–1127

    PubMed  CAS  Google Scholar 

  • Krieger MD, Couldwell WTC, Weiss MH: (1987) Assessment of Surgical Cure of Acromegaly. J Neurosurg 86:351

    Google Scholar 

  • ALamberts SWJ, del Pozo E: (1988) Somatostatin analog treatmentof acromegaly: New aspects. Hormone Res 29:115–117

    Article  Google Scholar 

  • Lamberts SWJ, Uitterlinden P, del Pozo E: (1987a) SMS 201–995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of164 M. D. Krieger et al.1234 acromegalic patients for over two years. J Clin Endodrinol Metab 65:201–995

    Article  Google Scholar 

  • Lamberts SWJ, Uitterlinden P, Verleun T: (1987b) Relationship between growth hormone and somatomedin-C levels in untreated acromegaly, after surgery and radiotherapyand during medical therapy with Sandostatin (SMS 201–995). Eur J Clin Invest 17:201–995

    Article  Google Scholar 

  • Lamberts SWJ, Uitterlinden P, Verschoor L, et al: (1985) Longterm treatment of acromegaly with the somatostatin analogue SMS 201–995. N Engl J Med 313:201–995

    Article  PubMed  CAS  Google Scholar 

  • Lamberts SWJ, Van Koetsveld P, Hofland L: (1989) A close correlation between the inhibitory effects of insulin-like growth factor-1 and SMS 201–995 on growth hormonerelease by acromegalic pituitary tumours in vitro and in vivo. Clin Endocrinol (Oxf) 31:201–995

    Article  CAS  Google Scholar 

  • Lamberts SWJ: (1988) The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocr Rev 9:417–436

    Article  PubMed  CAS  Google Scholar 

  • Landolt AM, Osterwalder V, Jantzer R, Stuckmann G: (1985) Pre-operative treatment of acromegaly with SMS 201–995: Surgical and pathological observations. Neuro Endocrinol Lett 7:94

    Google Scholar 

  • Landolt AM. (1981) Surgical treatment of pituitary prolactinomas: Postoperative prolactin and fertility in seventy patients. Fertil Steril 35:620–625

    PubMed  CAS  Google Scholar 

  • Laws ER, Fode NC, Redmond MJ. (1985) Transsphenoidal surgery following unsuccessful prior therapy. J Neurosurg 63: 823–829

    Article  PubMed  Google Scholar 

  • Laws ER, Kern EB: (1979) Complications of transsphenoidal surgery. p. 435. In Tindall GT, Collins WF (eds.): Clinical Management of Pituitary Disorders. Raven Press, New York

    Google Scholar 

  • Laws ER. (1996) Comment on paper by Massoud et al. Surg Neurol 45:344–345

    Google Scholar 

  • Leavens ME, Samaan NA, Jesse RH, Byers RM. (1977) Clinical and endocrinological evaluation of 16 acromegalic patients treated by transsphenoidal surgery. J Neurosurg 47: 853–860,

    Article  PubMed  CAS  Google Scholar 

  • Lees PD, Pickard JD: (1987) Hyperprolactinemia, intrasellar pituitary tissue pressure, and the pituitary stalk compression syndrome. J Neurosurg 767:192–196

    Google Scholar 

  • Leyeendecker G, Struve T, Plotz EJ: (1980) Induction of ovulationin chronic intermittent (pulsatile) administration of LH-RH in women with hypothalamic and hyperprolactinemic amenorrhea. Arch Gynecol 229:177–190

    Article  Google Scholar 

  • Lundin P, Nyman R, Burman P, et al: (1992) MRI of pituitary macroadenomas with reference to hormonal activity.Neuroradiology 34:43–51

    Google Scholar 

  • Maira G, Anile C, DeMarinis L, Barbarino A: (1989) Prolactinsecreting adenomas: Surgical results and long-term follow-up. Neurosurgery 24:736–743

    Article  PubMed  CAS  Google Scholar 

  • Martin NA, Hales M, Wilson CB: (1981) Cerebellar metastasis from a prolactinoma during treatment with bromocriptine. J Neurosurg 55:615–619

    Article  PubMed  CAS  Google Scholar 

  • Massoud F, Serri O, Hardy J, Somma M, Beauregard H: (1996) Transsphenoidal adenomectomy for microprolactinomas: 10 to 20 years of follow-up. Surg Neurol 45:341–346

    Article  PubMed  CAS  Google Scholar 

  • Masuda A, Shibasaki T, Kim YS, et al. (1989) The somatostatin analog octreotide inhibits the secretion of growth hormone (GH)-release hormone, thyrotropin and GH in man. J Clin Endocrinol Metab 69:906–1000

    Article  PubMed  CAS  Google Scholar 

  • Mcknight JA, McCance DR, Sheridan B, et al. (1991) Longterm dose-response study of somatostatin analogue (SMS 201–995, octreotide) in resistant acromegaly. Clin Endocrinol 34:201–995

    Article  CAS  Google Scholar 

  • Melmed S. (1990) Acromegaly. NEJM 322:966–977

    Google Scholar 

  • Molitch ME: (1992) Pathologic Hyperprolactinemia. Endocrinol Metab Clin North Am 21:877–901

    PubMed  CAS  Google Scholar 

  • Molitch ME: (1985) Pregnancy and hyperprolactinemic woman. N Engl J Med 312:1364–1370

    Article  PubMed  CAS  Google Scholar 

  • Moyse E, Le Dafniet M, Epelbaum J, et al: (1985) Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas. J Clin Endocrinol Metab 61:98–103

    Article  PubMed  CAS  Google Scholar 

  • Nabarro JDN. (1987) Acromegaly. Clin Endorinol 26:481–512

    Google Scholar 

  • Noell KT (1980) Prolactin and other hormone producing pituitary tumors: Radiation therapy. Clin Obstet Gynecol 23:441–452

    Article  PubMed  CAS  Google Scholar 

  • Ober K, Kelly D: (1988) Return of gonadal function with resection of nonfunctioning pituitary adenoma. Neurosurg 22:386

    Article  CAS  Google Scholar 

  • Oppizzi G, Petroncini MM, Dallabonzana D, et al: (1986) Relationship between somatomedin-C and growth hormone levels in acromegaly: Basal and dynamic evaluation. J Clin Endocrinol Metab 63:1348–1353

    Article  PubMed  CAS  Google Scholar 

  • Page MD, Millward ME, Hourihan M, et al: (1990) Long-term treatment of acromegaly with octreotide (Sandostatin).Horm Res 33(Suppl 1):20–31

    Google Scholar 

  • Physicians¡¯ desk reference, ed. 51. Medical Economics Company, 1997, pp 2411–2413

    Google Scholar 

  • Popovic V, Paunovic VR, Micic D, et al: (1987) The analgesiceffect and development of dependency to somatostatin analogue (octreotide) in headache associated with acromegaly. Horm Metab Res 20:250–251

    Article  Google Scholar 

  • Randall RV: (1991) Acromegaly and gigantism, in DeGroot LJ (ed): Endocrinology, 2nd ed. Philadelphia, W.B. Saunders Copp 330–350

    Google Scholar 

  • Raymond JP, Goldstein E, Konopka P, et al: (1985) Follow-up of children born of bromocriptine-treated mothers. Horm Res 22:239–246

    Article  PubMed  CAS  Google Scholar 

  • Reubi JC, Landolt AM: (1989) The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status. J Clin Endocrinol Metab 68:844–850

    Article  PubMed  CAS  Google Scholar 

  • Ross DA, Wilson CB. (1988) Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients. J Neurosurg 68: 854–867

    Article  PubMed  CAS  Google Scholar 

  • Sadoul J-L, Thyss A, Freychet P: (1992) Invasive mixed growth hormone/prolactin secreting pituitary tumour: Complete shrinking by octreotide and bromocriptine and lack of tumour growth relapse 20 months after octreotide withdrawal. Acta Endocrinol 126:179–183

    PubMed  CAS  Google Scholar 

  • Sandler LM, Burrin JM, Williams G, et al: (1987) Effective long-term treatment of acromegaly with a long-acting somatostatin analog (SMS 201–995). Clin Endocrinol (Oxf) 26:201–995

    Article  CAS  Google Scholar 

  • Schlechte J, Dolan K, Sherman B, et al: (1989) The natural history of untreated hyperprolactinemia: A prospective analysis. J Clin Endocrinol Metab 68:412–418

    Article  PubMed  CAS  Google Scholar 

  • Serri O, Rasio E, Beauregard H, et al: (1983) Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma. N Engl J Med 309:280–283

    Google Scholar 

  • Serri O, Robert F, Comtois R, et al: (1987) Distinctive features of prolactin secretion in acromegalic patients with hyperprolactinaemia. Clin Endocrinol 27:429–436

    Article  CAS  Google Scholar 

  • Serri O, Somma M, Comtoid R, et al: (1985) Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy. J Clin Endocrinol Metab 61: 1185–1189

    Article  PubMed  CAS  Google Scholar 

  • Sheline GF: (1974) Treatment of non-functioning chromophobe adenomas of the pituitary. Am J Roentgenol 120:553–561

    Article  CAS  Google Scholar 

  • Sisam DA, Sheehan JP, Sheeler LR: (1987) The natural history of untreated microprolactinomas. Fertil Steril 48:67–71

    PubMed  CAS  Google Scholar 

  • Skrabanek P, McDonald D, Meager D, et al: (1980) Clinical course and outcome of thirty-five pregnancies in infertile hyperprolactinemic women. Fertil Steril 33:391–395

    PubMed  CAS  Google Scholar 

  • Spinas GA, Zaph J, Landolt AM, et al: (1987) Pre-operative treatment of 5 acromegalics with a somatostatin analogue: Endocrine and clinical observations. Acta Endocrinol (Copenh) 114:249–256

    CAS  Google Scholar 

  • Thomson JA, Davies DL, McLaren EH, Teasdale GM: (1994) Ten year follow up of microprolactinoma treated by transsphenoidal surgery. Br Med J 309:1409–1410

    Article  CAS  Google Scholar 

  • Thorner MO, McNeilly AS, Hagen C, et al: (1974) Long-term treatment of galactorrhea and hypogonadism with bromocriptine. Br Med J 2:419–422

    Article  PubMed  CAS  Google Scholar 

  • Thorner MO, Perryman RL, Rogol AD, et al: (1981) Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine. J Clin Endocrinol Metab 53:480–483

    Article  PubMed  CAS  Google Scholar 

  • Thorner MO: Prolactinoma, in Bardin CW (ed): (1991) Current Therapy in Endocrinology and Metabolism, 4th ed. Philadelphia, B.C. Decker Inc, pp 35–38

    Google Scholar 

  • Tindall GT, Oyesiku NM, Watts NB, Clark RV, Christy JH, Adams DA. (1993) Transsphenoidal adenomectomy forgrowth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure. J Neurosurg 78: 205–215

    Article  PubMed  CAS  Google Scholar 

  • Tucker HS, Grubb SR, Wigand JP, Watlington CO, Blackard WG, Becker DP. (1980) The Treatment of Acromegaly by Transsphenoidal Surgery. Arch Intern Med 140: 795–802.

    Article  PubMed  CAS  Google Scholar 

  • Turkalj I, Braun P, Krupp P: (1982) Surveillance of bromocriptine in pregnancy. JAMA 247:1589–1591

    Article  PubMed  CAS  Google Scholar 

  • Urdaneta N, Chessin H, Fisher JJ: (1975) Pituitary adenomas and craniopharyngiomas. Analysis of 99 cases treated with radiation therapy. Int J Radiat Oncol Biol Phys 1:895–902

    Article  Google Scholar 

  • Valtonen S, Myllymaki K: (1986) Outcome of patients after transcranial operation for pituitary adenoma. Ann Clin Res 18(Suppl 47):43–45

    PubMed  Google Scholar 

  • Van Roon E, Van der Vijver JCM, Gerretsen G, et al: (1981) Rapid regression of a suprasellar extending prolactinoma after bromocriptine treatment during pregnancy. Fertil Steril 36:173–177

    PubMed  CAS  Google Scholar 

  • Vance ML, Evans WS, Thorner MO: (1984) Drugs five years later: Bromocriptine. Ann Intern Med 100:78–91

    PubMed  CAS  Google Scholar 

  • Vance ML, Thorner MO: (1987) Prolactinomas. Endocrinol Metab Clin 16:731–753

    Google Scholar 

  • Wass JAH, Anderson JV, Besser GM, Dowling RH: (1989) Gall stones and treatment with octreotide for acromegaly. Br Med J 299:1162–1163

    Article  Google Scholar 

  • Wass JAH: (1990) Octreotide treatment of acromegaly. Horm Res 33(Suppl 1):1–6

    Article  PubMed  Google Scholar 

  • Wass JAM, Thorner MO, Morris DV, et al: (1977) Long-term treatment of acromegaly with bromocriptine. Br Med J 1:875–878

    Article  PubMed  CAS  Google Scholar 

  • Webster J, Page MD, Bevan JS, Richards SH, Douglas-Jones AG, Scanlon MF: (1992) Low recurrence rate after partial hypophysectomy for prolactinoma: The predictive value of dynamic prolactin function tests. Clin Endocrin 36:35–44

    Article  CAS  Google Scholar 

  • Weiss MH, Teal J, Gott P, et al: (1983) Natural history of microprolactinomas: Six year follow-up. Neurosurgery 12:180–182

    Article  PubMed  CAS  Google Scholar 

  • Weiss MH, Wycoff RR, Yadley R, et al: (1983) Bromocriptine treatment of prolactin-secreting tumors: Surgical implications. Neurosurgery 12:640–642, 1983

    Google Scholar 

  • Weiss MH: (1980) In Horvath K, Kaufman F, Kovacs E, Wiess MH (eds.): Pituitary Diseases. CRC Press, Bocan Raton, FL, p 180

    Google Scholar 

  • White MC, Newland P, Daniels M, et al: (1986) Growth hormone secreting pituitary adenomas are heterogeneous in cell culture and commomly secrete glycoprotein hormone alpha-subunit. Clin Endocrinol (Oxf) 25:173–179

    Article  CAS  Google Scholar 

  • Williams G, Ball J, Lawson R, et al: (1987) Analgesic effect of somatostatin analogue (octreotide) in headache associated with pituitary tumors. Br Med J 295:247–248

    Article  CAS  Google Scholar 

  • Wilson CB, Dempsey LC: (1978) Transsphenoidal microsurgicalremoval of 250 pituitary adenomas. J Neurosurg; 48:13. Wilson CB: (1984) A decade of pituitary microsurgery. J Neurosurg 61:814–833

    Google Scholar 

  • Wray SH: (1977) Neuro-opthalmologic manifestations of pituitary and parasellar lesions. Clin Neurosurg; 24:86

    PubMed  CAS  Google Scholar 

  • Wright AD, Hill DM, Lowry C, Fraser TR: (1970) Mortality in acromegaly. Q J Med 39: 1–16

    PubMed  CAS  Google Scholar 

  • Zarate A, Canales ES, Cano C, Pilonieta CJ: (1983) Follow-up of patients with prolactinomas after discontinuation of long-term therapy with bromocriptine. Acta Endocrinol (Copenh) 104:139–142

    CAS  Google Scholar 

  • Zervas NT: (1984) Surgical results for pituitary adenomas: Results of an international survey, in Black PMcL, Zervas NT, Ridgeway EC (eds): Secretory tumors of the pituitarygland. New York, NY, Raven Press, pp 377–385

    Google Scholar 

Download references

Authors
  1. Mark D. Krieger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arun P. Amar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin H. Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, University of Southern California, Keck School of Medicine 1441 Eastlake Avenue, Room G356, Los Angeles, CA, 90033-0804, USA

    Zbigniew Petrovich MD, FACR (Professor and Chairman) (Professor and Chairman)

  2. Department of Radiation Oncology, Hahnemann University Hospital, Broad & Vine Sts., Mail Stop 200, Philadelphia, PA, 19102, USA

    Luther W. Brady MD (Hylda Cohn/ American Cancer Society Professor of Clinical Oncology and Professor) (Hylda Cohn/ American Cancer Society Professor of Clinical Oncology and Professor)

  3. Keck School of Medicine of the University of Southern California, Los Angeles, CA, 90033, USA

    Michael L. J. Apuzzo MD (Edwin M. Todd/Trent H. Wells, Jr. Professor of Neurological Surgery and Professor of Radiation Oncology) (Edwin M. Todd/Trent H. Wells, Jr. Professor of Neurological Surgery and Professor of Radiation Oncology)

  4. Department of Radiotherapy, Eberhard-Karls-Universität, Hoppe-Seyler-Strasse 3, 72076, Tübingen, Germany

    Michael Bamberg MD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Krieger, M.D., Amar, A.P., Weiss, M.H. (2003). Surgical Management of Pituitary Adenoma. In: Petrovich, Z., Brady, L.W., Apuzzo, M.L.J., Bamberg, M. (eds) Combined Modality Therapy of Central Nervous System Tumors. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56411-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56411-6_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-00627-5

  • Online ISBN: 978-3-642-56411-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation